Bexson Biomedical
Santa Barbara
About Bexson Biomedical
Bexson Biomedical is developing a unique formulation of ketamine for chronic and acute pain disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2021)
- Website: bexsonbiomedical.com
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bexson-biomedical-114465 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.